Health utility in relapsed/refractory diffuse large B-cell lymphoma (RR-DLBCL) patients : results of a phase II trial with oral selinexor
René-Olivier Casasnovas,Patrick Daniele,Gabriel Tremblay,Marie Maerevoet,Josee M. Zijlstra,George A. Follows,Joost S.P. Vermaat,Nagesh Kalakonda,Andre Goy,Sylvain Choquet, E. Van Den Neste,Brian T. Hill,Catherine Thieblemont,Federica Cavallo,F. de la Cruz,John Kuruvilla,Nada Hamad,R. Bouabdallah,Ulrich Jaeger,Paolo Caimi,Ronit Gurion,Krzysztof Warzocha,Sameer Bakhshi,Juan-Manuel Sancho,Michael W. Schuster,Miklos Egyed,Fritz Offner, Theodoros Vasilakopoulos,Priyanka Samal,Ágnes Nagy,Matthew Ku, M. A. Canales Albendea Value in Health（2020）
关键词
lymphoma,oral selinexor,b-cell,rr-dlbcl
AI 理解论文
溯源树
样例
